Skip to main content
Biocartis' EGFR mutation test wins EU approval
6/14/2017

European regulators have given Biocartis CE mark approval for its Idylla EGFR Mutation Test for lung cancer. The PCR-based test, which requires hands-on time of less than two minutes, directly detects 51 EGFR mutations from a slice of FFPE tissue and produces results in 2.5 hours.

Full Story: